Dr. Paul Lohmann

Dr. Paul Lohmann presents two focus areas for their CPhI Frankfurt booth: Mineral Salts as APIs  The Dr. Paul Lohmann...

Abstract Lornoxicam, a potent nonsteroidal anti-inflammatory drug (NSAID), suffers from poor aqueous solubility, leading to limited dissolution and variable bioavailability....

Abstract Localized vaginal drug delivery can offer safer and more effective treatment options for various conditions, also for pregnant women....

Abstract Sodium caprate (C10) is the most investigated permeation enhancer to promote oral peptide absorption. However, the clinical translation of...

Abstract Poly-2-hydroxypropane-1,2,3-tricarboxylic carubin (P-2HTCb) has characteristics as a glidant similar to talc and magnesium stearate (MgSt), such as irregular shape,...

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...

Abstract Objectives The study aimed to combine instant-release and mini-tablet methodologies to develop novel orally disintegrating mini-tablets (ODMTs) for a...

Abstract This paper presents a proof of concept for a novel pharmaceutical analytical tool, which utilizes a UV imaging-based machine...

  What are Fake Minerals? In the field of chelated compounds, “fake minerals” are products marketed as chelates but lacking...

Abstract Purpose This study aims to evaluate the ability of various cyclodextrins (CDs) to enhance the aqueous solubility of haloperidol...